Fortescue Metals Group has hit back at critics of chairman Andrew Forrest’s controversial call for an effective iron ore production cartel to address collapsing prices, accusing the company’s rivals of exacerbating industry cycles and causing a “massive” transfer of wealth out of the country.
FMG chief executive Neville Power staunchly defended comments by his chairman in Shanghai earlier this week. “If you look at our industry, the current iron ore price is not good for anyone,” he said.
Chinese steel giant Baosteel, which was Fortescue’s first customer, joined the growing condemnation, saying Mr Forrest’s call for a cap on iron ore output to revive prices was “not good for fair competition”
“Companies should follow the laws of the market,” Baosteel chief financial officer Zhu Kebing was yesterday quoted by Reuters.
In response the FMG chief said they would much prefer consistency and stability in prices rather than wild swings.
A lot of customers, he said, wanted to return to the old mechanism of benchmark pricing, where prices were set as a result of annual negotiations between producers and customers.
“I think spot pricing is better because it promotes the right signals back into the market and creates transparency,” Mr Power said.
Full Content: The Australian Business Review
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas